Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2015

Dec 17, 2015

29831_dirs_2015-12-16_6b34c3ea-ce22-41a9-bccb-4a1c676a85d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2015-12-15

Reporting Person: BOURLA ALBERT (Group President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-15 Common Stock M 30000.0000 $26.2000 Acquired 140560.0000 Direct
2015-12-15 Common Stock F 27195.0000 $32.4700 Disposed 113365.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-15 Employee Stock Option (right to buy) $26.2000 M 30000.0000 Disposed 2016-02-22 Common Stock (30000.0000) Direct
2015-12-15 Phantom Stock Units SSP $ A 20.0000 Acquired Common Stock (20.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2185.0000 Indirect

Footnotes

F1: The reported transaction constitutes the withholding of shares which were retained by the Issuer to satisfy the payment of the exercise price and tax obligations in connection with an exercise of stock options through a net settlement.

F2: These options are fully exercisable.

F3: Each unit represents one phantom share of common stock.

F4: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.